Product Details for ANDA 091633
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE; IBUPROFEN)
2.5MG;200MG
Marketing Status: Discontinued
5MG;200MG
Marketing Status: Discontinued
7.5MG;200MG
Marketing Status: Discontinued
10MG;200MG
Marketing Status: Discontinued
2.5MG;200MG
Marketing Status: Discontinued
Active Ingredient: HYDROCODONE BITARTRATE; IBUPROFEN
Proprietary Name: HYDROCODONE BITARTRATE AND IBUPROFEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG;200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091633
Product Number: 001
Approval Date: May 28, 2013
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE; IBUPROFEN)
Proprietary Name: HYDROCODONE BITARTRATE AND IBUPROFEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG;200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091633
Product Number: 001
Approval Date: May 28, 2013
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
5MG;200MG
Marketing Status: Discontinued
Active Ingredient: HYDROCODONE BITARTRATE; IBUPROFEN
Proprietary Name: HYDROCODONE BITARTRATE AND IBUPROFEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091633
Product Number: 002
Approval Date: May 28, 2013
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE; IBUPROFEN)
Proprietary Name: HYDROCODONE BITARTRATE AND IBUPROFEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091633
Product Number: 002
Approval Date: May 28, 2013
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
7.5MG;200MG
Marketing Status: Discontinued
Active Ingredient: HYDROCODONE BITARTRATE; IBUPROFEN
Proprietary Name: HYDROCODONE BITARTRATE AND IBUPROFEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG;200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091633
Product Number: 003
Approval Date: May 28, 2013
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE; IBUPROFEN)
Proprietary Name: HYDROCODONE BITARTRATE AND IBUPROFEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG;200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091633
Product Number: 003
Approval Date: May 28, 2013
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
10MG;200MG
Marketing Status: Discontinued
Active Ingredient: HYDROCODONE BITARTRATE; IBUPROFEN
Proprietary Name: HYDROCODONE BITARTRATE AND IBUPROFEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG;200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091633
Product Number: 004
Approval Date: May 28, 2013
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: HYDROCODONE BITARTRATE AND IBUPROFEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG;200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091633
Product Number: 004
Approval Date: May 28, 2013
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Discontinued
Patent and Exclusivity Information